TCL科技:公司擬以自有資金向TCL華星增資50億元 持股比例將提升2%
格隆匯5月21日丨TCL科技(000100.SZ)公吿,公司擬對公司控股子公司TCL華星進行增資,公司以自有資金向TCL華星增資50億元,參照三星顯示株式會社2021年3月對TCL華星增資作價,確定本次增資價格為1.5525元/1元註冊資本。本次增資完成後,公司持有TCL華星的股權比例由81.02%提升至83.02%,隨着行業投資回報率的提高,公司的持續盈利能力將得到增強;另一方面,公司進一步加強了對TCL華星的管理與控制力,有助於加強對TCL華星經營的各方面支持,進一步提升公司的綜合競爭力和盈利能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.